AlphaYouCT
Insider selling
Cameron Turtle sold $1.4M of Spyre Therapeutics, Inc. (SYRE) stock
Cameron Turtle, Chief Executive Officer of Spyre Therapeutics, Inc. (SYRE), sold 15,000 shares of SYRE stock worth $1.4M, per an SEC Form 4 filed Oct 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 2 days before it was made public.
SYRE has moved +3.6% since the trade date, from $89.93 to $93.19 (Oct 2, 2026 close).
- Traded
- Oct 1, 2026
- Disclosed
- Oct 3, 2026
- Filing delay
- 2 days
- Price since
- +3.6%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More SYRE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.